VERU INC. Long-term Line of Credit, Noncurrent
VERU INC. (VERU) had Long-term Line of Credit, Noncurrent of $2.33 million as of 2020-03-31, per its 10-Q filed 2020-05-13.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Long-Term Debt and Lease Obligation › Long-Term Debt, Excluding Current Maturities
us-gaap:LongTermLineOfCredit · last filed 2020-12-10
- 2020-03-31: Long-term Line of Credit, Noncurrent $2.33M.
- 2019-12-31: Long-term Line of Credit, Noncurrent $1.91M.
- 2019-09-30: Long-term Line of Credit, Noncurrent $2.89M.
- 2019-06-30: Long-term Line of Credit, Noncurrent $4.49M.
| Period end | Long-term Line of Credit, Noncurrent |
|---|---|
| 2020-03-31 | $2.33M 10-Q · filed 2020-05-13 |
| 2019-12-31 | $1.91M 10-Q · filed 2020-02-12 |
| 2019-09-30 | $2.89M 10-K · filed 2020-12-10 |
| 2019-06-30 | $4.49M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $2.72M 10-Q · filed 2019-05-15 |
| 2018-12-31 | $3.00M 10-Q · filed 2019-02-13 |
| 2018-09-30 | $2.70M 10-K · filed 2019-12-12 |
| 2018-06-30 | $4.27M 10-Q · filed 2018-08-14 |
| 2018-03-31 | $5.82M 10-Q · filed 2018-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |